FBXW7 mutations reprogram glucose metabolism by activating the ETV6-GLUT1 axis
Abstract The progression of endometrial cancer (EC) involves substantial metabolic reprogramming, frequently driven by mutations in tumor suppressors and oncogenes. In this study, we identify a previously unrecognized pathway through which FBXW7 mutations rewire glucose metabolism in EC cells. Speci...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-02-01
|
| Edice: | Molecular Cancer |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12943-026-02605-w |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
